MAPT and Brain atrophy: In the ADNI group, higher plasma Tau levels (P-Tau from 3.44 pg/ml to 8.89 pg/ml) predicted a rate of cognitive decline, an increase in brain atrophy measured with MRI, and a decrease in cortical glucose metabolism as shown by FDG-PET [80].